AbSci Garners $5,100,000 Series A Funding Round

  • Feed Type
  • Date
  • Company Name
  • Mailing Address
    4640 SW Macadam Ave. Portland, OR 97239 USA
  • Company Description
    AbSci is a global leader in cutting-edge protein production technologies committed to reducing costs in the biopharmaceutical industry.
  • Website
  • Transaction Type
    Venture Equity
  • Transaction Amount
  • Transaction Round
    Series A
  • Proceeds Purposes
    Funding will accelerate commercialization of AbSci’s SoluPro™ protein expression platform for use in biopharmaceutical manufacturing.
  • M&A Terms
  • Venture Investor
    Phoenix Venture Partners
  • Venture Investor

Trending on Xconomy